All Articles

Ritholtz Wealth Management is deploying AI firmwide, but the real story is the compliance tech making it possible. A look at the future of regulated AI.

A UK Court of Appeal ruling has overturned a massive award for AXA against Santander, showcasing the long, costly tail of the PPI scandal and its complex impact on firms like Genworth.

Praxent's new board signals a market-wide shift from AI experiments to regulated, production-ready systems. Is the industry finally ready to move past the hype?

The IT distribution giant bets its future on an AI-powered platform, Xvantage™, promising radical efficiency and ambitious profit growth. But can it deliver?

A shell company pivots to become a gold explorer, acquiring a risky but promising Finnish property. A deep dive into the complex deal shaping a new player.

Amtech Software unveils a cloud ERP, advanced analytics, and full traceability for Label Traxx, aiming to free converters from IT burdens and unlock data.

The Wild West of crypto marketing is facing a new sheriff. Wanted Network's "Missions" model aims to replace vanity metrics with measurable ROI.

As cybercrime costs soar despite record security spending, a new doctrine is emerging—one that blends national intelligence tactics with corporate security.

PrimeStone Capital urges a sale of Gresham House Energy Storage Fund, citing a 26% value gap. The board resists, betting on un-booked data center revenues.

A Canadian-led project in Rwanda wildly surpassed its goals, transforming women's health. Now, as funding ends, a call to expand this proven model faces global aid cuts.

Xylo Bio's new drug for depression enters trials, betting it can rewire the brain without the hallucinogenic burden. Is this the future of mental healthcare?

TOLREMO's successful Phase I trial for TT125-802 validates a novel strategy against NSCLC, offering new hope by targeting cancer's clever escape routes.

With half its counties lacking obstetric care, Arkansas is funding a novel program pairing community doulas with a digital platform to save rural mothers.

As AI moves into robots and cars, Exein's record funding signals a new cybersecurity frontier. But can its machine-trained AI truly defend our physical world?

How one Singaporean health system's quiet experiment in value-based care became a national playbook, saving millions and redefining patient outcomes.

NewHydrogen's plan to make the 'world's cheapest clean hydrogen' takes a critical step, siting its pilot plant at a Utah state research facility.

ScoliCare's new Durham clinic taps into a growing demand for non-surgical scoliosis care, challenging traditional treatment models with its tech-driven approach.

A new survey reveals nearly 40% of data center staff plan to quit, despite pay hikes. The engine of our digital world is sputtering, not for lack of fuel, but for a flawed design.

As startups pivot from dilutive equity to complex debt, a new intelligence platform called Undiluted launches to map this fragmented, multi-billion dollar market.

As the Tech in Asia Conference returns to Singapore, the region's businesses are moving past experimentation. The new focus: tackling the hard problems of scaling AI.